Literature DB >> 18544210

Initial default from tuberculosis treatment: how often does it happen and what are the reasons?

E Botha1, S Den Boon, S Verver, R Dunbar, K-A Lawrence, M Bosman, D A Enarson, I Toms, N Beyers.   

Abstract

A study in 11 primary health care facilities in and around Cape Town determined the proportion of bacteriologically confirmed tuberculosis (TB) cases who did not start treatment (initial default) and identified reasons for it. Databases from centralised laboratories were compared with electronic TB treatment registers. Fourteen per cent (373/2758) of TB suspects were TB cases. Of the 58 (16%) initial defaulters, 14 (24%) died, while 26 (45%) could not be interviewed for address-related reasons. The 18 subjects who were interviewed indicated reasons for initial default that were (56%) or were not (44%) directly linked to services. High initial default rates require improvement in the quality of health services.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18544210

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  46 in total

1.  Pre-treatment loss to follow-up among smear-positive pulmonary tuberculosis cases: a 10-year audit of national data from Fiji.

Authors:  S Ram; K Kishore; I Batio; K Bissell; R Zachariah; S Satyanarayana; A D Harries
Journal:  Public Health Action       Date:  2012-12-21

2.  Modeling the impact of alternative strategies for rapid molecular diagnosis of tuberculosis in Southeast Asia.

Authors:  Amanda Y Sun; Madhukar Pai; Henrik Salje; Srinath Satyanarayana; Sarang Deo; David W Dowdy
Journal:  Am J Epidemiol       Date:  2013-10-07       Impact factor: 4.897

3.  Diagnosis and treatment of TB patients with rifampicin resistance detected using Xpert(®) MTB/RIF in Zimbabwe.

Authors:  K Charambira; S Ade; A D Harries; R T Ncube; C Zishiri; C Sandy; H Mutunzi; K Takarinda; P Owiti; P Mafaune; P Chonzi
Journal:  Public Health Action       Date:  2016-06-21

4.  Comprehensiveness of primary services in the care of infectious tuberculosis patients in Rawalpindi, Pakistan.

Authors:  R Fatima; Q Ejaz; D A Enarson; K Bissell
Journal:  Public Health Action       Date:  2011-09-21

5.  Alarming rates of attrition among tuberculosis patients in public-private facilities in Lahore, Pakistan.

Authors:  B J Khan; A M V Kumar; A Stewart; N M Khan; K Selvaraj; R Fatima; Z Samad
Journal:  Public Health Action       Date:  2017-06-21

6.  The disconnect between a national tuberculosis drug resistance survey and treatment outcomes: a lost opportunity.

Authors:  E S Click; J Chirenda; S Kibias; H J Menzies; J E Oeltmann; C Sentle; T Muribe; T D Lere; R Makombe; S Bamrah; B K Moore; K P Cain
Journal:  Int J Tuberc Lung Dis       Date:  2014-11       Impact factor: 2.373

7.  Point of care Xpert MTB/RIF versus smear microscopy for tuberculosis diagnosis in southern African primary care clinics: a multicentre economic evaluation.

Authors:  Anil Pooran; Grant Theron; Lynn Zijenah; Duncan Chanda; Petra Clowes; Lawrence Mwenge; Farirai Mutenherwa; Paul Lecesse; John Metcalfe; Hojoon Sohn; Michael Hoelscher; Alex Pym; Jonny Peter; David Dowdy; Keertan Dheda
Journal:  Lancet Glob Health       Date:  2019-06       Impact factor: 26.763

8.  Investigating Barriers to Tuberculosis Evaluation in Uganda Using Geographic Information Systems.

Authors:  Jennifer M Ross; Adithya Cattamanchi; Cecily R Miller; Andrew J Tatem; Achilles Katamba; Priscilla Haguma; Margaret A Handley; J Lucian Davis
Journal:  Am J Trop Med Hyg       Date:  2015-07-27       Impact factor: 2.345

9.  Test and treat: a new standard for smear-positive tuberculosis.

Authors:  J Lucian Davis; David W Dowdy; Saskia den Boon; Nicholas D Walter; Achilles Katamba; Adithya Cattamanchi
Journal:  J Acquir Immune Defic Syndr       Date:  2012-09-01       Impact factor: 3.731

Review 10.  Pre-treatment loss to follow-up in tuberculosis patients in low- and lower-middle-income countries and high-burden countries: a systematic review and meta-analysis.

Authors:  Peter MacPherson; Rein M G J Houben; Judith R Glynn; Elizabeth L Corbett; Katharina Kranzer
Journal:  Bull World Health Organ       Date:  2013-11-22       Impact factor: 9.408

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.